An Update on Clostridioides difficile Binary Toxin

Toxins (Basel). 2022 Apr 27;14(5):305. doi: 10.3390/toxins14050305.

Abstract

Infection with Clostridioides difficile (CDI), a common healthcare-associated infection, includes symptoms ranging from mild diarrhea to severe cases of pseudomembranous colitis. Toxin A (TcdA) and toxin B (TcdB) cause cytotoxicity and cellular detachment from intestinal epithelium and are responsible for CDI symptomatology. Approximately 20% of C. difficile strains produce a binary toxin (CDT) encoded by the tcdA and tcdB genes, which is thought to enhance TcdA and TcdB toxicity; however, the role of CDT in CDI remains controversial. Here, we focused on describing the main features of CDT and its impact on the host, clinical relevance, epidemiology, and potential therapeutic approaches.

Keywords: Clostridioides difficile; binary toxin; epidemiology; hypervirulent strains.

Publication types

  • Review

MeSH terms

  • Antibodies, Bacterial
  • Bacterial Toxins* / genetics
  • Bacterial Toxins* / toxicity
  • Clostridioides difficile* / genetics
  • Cross Infection*
  • Enterocolitis, Pseudomembranous*
  • Humans

Substances

  • Antibodies, Bacterial
  • Bacterial Toxins

Grants and funding

This research received no external funding.